Medication info
Duclai 30/2.5 mg Film-Coated Tablets

Duclai 30/2.5 mg Film-Coated Tablets

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›33.005mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
White, rounded-square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300129 · Approved 2023.01.06 · Insurance code 647304480

Summary

Main use
Treatment of essential hypertension not controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted with fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or with this medicine 60/2.5 milligrams. For patients taking fimasartan and S-amlodipine (amlodipine) concomitantly, switching to this medicine (a combination product containing the same amounts of each active ingredient) may be considered for convenience. Older adults No initial dose adjustment is required for older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment with the fimasartan 30 milligrams component of this medicine should be initiated. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

This medication is used to effectively lower blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of Pimasartan Potassium. It helps improve blood pressure control, thereby reducing the risk of cardiovascular diseases.

How to take

Adult dose

Adults The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted with fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 30 milligrams as monotherapy. ㆍ 60/2.5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy. ㆍ 60/5 milligrams: For patients whose blood pressure is not adequately controlled with fimasartan 60 milligrams as monotherapy or with this medicine 60/2.5 milligrams. For patients taking fimasartan and S-amlodipine (amlodipine) concomitantly, switching to this medicine (a combination product containing the same amounts of each active ingredient) may be considered for convenience. Older adults No initial dose adjustment is required for older adults aged 70 years or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). However, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment with the fimasartan 30 milligrams component of this medicine should be initiated. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy in pediatric and adolescent patients aged 18 years or younger have not been established.

Precautions

This drug may cause serious harm or death to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. This drug should not be used in patients with allergies to its active ingredients or related substances, pregnant or lactating women, patients undergoing kidney dialysis, patients with moderate to severe liver dysfunction, and patients with bile duct obstruction. Patients with certain renal insufficiencies or who are taking specific medications, as well as those with genetic metabolism disorders such as lactose intolerance, should avoid taking this drug. Special caution is needed when administering this drug to patients with low blood volume or salt deficiency, reduced kidney function, renal artery hypertension, aortic or mitral stenosis, severe hypotension, and elderly patients. This drug can cause allergic reactions to certain dye components, so patients with sensitivities to these components should use it cautiously. During treatment, side effects such as dizziness, headache, edema, urinary disturbances, insomnia, and flushing may occur; if these symptoms are severe, consulting a doctor is advised. Blood pressure may drop too low, so monitoring should be conducted when starting or increasing the dose, and appropriate measures should be taken if hypotension symptoms arise. This drug can affect kidney function, so patients with kidney diseases require regular checks. Drug interactions may occur when taken with other antihypertensives, specific diuretics, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so inform your doctor about all medications being taken. Pregnant or nursing women should consult a doctor before taking this medication and should preferably stop breastfeeding or taking the medication while breastfeeding. Safety and efficacy in children and adolescents under 18 years of age have not been established, and use is not recommended. In case of overdose, severe hypotension or cardiac arrhythmias may occur, so immediate medical attention should be sought for proper treatment. This medication should be kept out of reach of children and care should be taken not to transfer it to another container as it may adversely affect the quality of the drug.

Side effects

  • Dizziness
  • orthostatic dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urinary disturbance
  • insomnia
  • flushing
  • syncope
  • sedative
Show 124 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • increased liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • itching
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuromyopathy
  • neurocytitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified nature
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • worsening low back pain
  • osteoarthritis
  • arthrosis
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • increased blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • weakness
  • fatigue
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • increased tone
  • sensory decrease
  • dysesthesia
  • peripheral neuropathy
  • taste disturbance
  • tremor
  • extrapyramidal dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • dyspepsia
  • gingival hypertrophy
  • pancreatitis
  • sweating
  • hair loss
  • hyperhidrosis
  • purpura
  • skin discoloration
  • urticaria
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • nocturia
  • hepatitis
  • jaundice
  • increased liver enzyme levels
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • constipation
  • skin flushing
  • maculopapular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • debility

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be stored in a container that prevents light exposure. Additionally, it is recommended to store the medication at room temperature, between 1°C and 30°C. This helps maintain the effectiveness of the drug over time.

Appearance and packaging

Appearance

White, rounded-square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.